首页> 外文期刊>European journal of pain : >Comparison of pulsed radiofrequency with conventional radiofrequency in the treatment of idiopathic trigeminal neuralgia.
【24h】

Comparison of pulsed radiofrequency with conventional radiofrequency in the treatment of idiopathic trigeminal neuralgia.

机译:脉冲射频与常规射频在特发性三叉神经痛治疗中的比较。

获取原文
获取原文并翻译 | 示例
       

摘要

The aim of this prospective, randomized, double-blinded study was to evaluate the effect of pulsed radiofrequency (PRF) in comparison with conventional radiofrequency (CRF) in the treatment of idiopathic trigeminal neuralgia. A total of 40 patients with idiopathic trigeminal neuralgia were included. The 20 patients in each group were randomly assigned to one of the two treatment groups. Each patient in the Group 1 was treated with CRF, whereas each patient in the Group 2 was treated by PRF. Evaluation parameters were: pain intensity using a Visual Analogue Scale (VAS), patient satisfaction using a Patient Satisfaction Scale (PSS), additional pharmacological treatment, side effects, and complications related to the technique. The VAS scores decreased significantly (p<0.001) and PSS improved significantly after the procedure in Group 1. The VAS score decreased in only 2 of 20 patients from the PRF group (Group 2) and pain recurrence occurred 3 months after the procedure. At the end of 3 months, we decided to perform CRF in Group 2, because all patients in this group still had intractable pain. After the CRF treatment, the median VAS score decreased (p<0.001) and PSS improved (p<0.001) significantly. In conclusion, the results of our study demonstrate that unlike CRF, PRF is not an effective method of pain treatment for idiopathic trigeminal neuralgia.
机译:这项前瞻性,随机,双盲研究的目的是评估脉冲射频(PRF)与常规射频(CRF)相比在特发性三叉神经痛中的作用。总共包括40例特发性三叉神经痛患者。每组20例患者被随机分配至两个治疗组之一。第1组的每位患者均接受CRF治疗,而第2组的每位患者均接受PRF治疗。评估参数为:使用视觉模拟量表(VAS)的疼痛强度,使用患者满意度量表(PSS)的患者满意度,其他药物治疗,副作用以及与该技术相关的并发症。第1组手术后,VAS评分显着下降(p <0.001),PSS显着改善。PRF组(第2组)的20例患者中只有2例的VAS评分下降,并且术后3个月疼痛复发。在3个月末,我们决定在第2组中进行CRF,因为该组中的所有患者仍存在顽固性疼痛。 CRF治疗后,VAS评分中位数下降(p <0.001),PSS明显改善(p <0.001)。总之,我们的研究结果表明,与CRF不同,PRF并不是治疗特发性三叉神经痛的有效方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号